Alice K. Tanner, Ph.D.
Affiliations: | 2004 | Duke University, Durham, NC |
Area:
Genetics, Medicine and Surgery, Molecular BiologyGoogle:
"Alice Tanner"Parents
Sign in to add mentorBruce A. Sullenger | grad student | 2004 | Duke | |
(Reducing intimal hyperplasia using RNA aptamers to inhibit E2F function.) |
BETA: Related publications
See more...
Publications
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
Nallamilli BRR, Chakravorty S, Kesari A, et al. (2018) Genetic landscape and novel disease mechanisms from a large LGMD cohort of 4656 patients. Annals of Clinical and Translational Neurology. 5: 1574-1587 |
Ankala A, da Silva C, Gualandi F, et al. (2015) A comprehensive genomic approach for neuromuscular diseases gives a high diagnostic yield. Annals of Neurology. 77: 206-14 |
Tanner AK, Valencia CA, Rhodenizer D, et al. (2014) Development and performance of a comprehensive targeted sequencing assay for pan-ethnic screening of carrier status. The Journal of Molecular Diagnostics : Jmd. 16: 350-60 |
Askree SH, Chin EL, Bean LH, et al. (2013) Detection limit of intragenic deletions with targeted array comparative genomic hybridization. Bmc Genetics. 14: 116 |
Jones MA, Rhodenizer D, da Silva C, et al. (2013) Molecular diagnostic testing for congenital disorders of glycosylation (CDG): detection rate for single gene testing and next generation sequencing panel testing. Molecular Genetics and Metabolism. 110: 78-85 |
Tanner AK, Chin EL, Duffner PK, et al. (2012) Array CGH improves detection of mutations in the GALC gene associated with Krabbe disease. Orphanet Journal of Rare Diseases. 7: 38 |
Giangrande PH, Zhang J, Tanner A, et al. (2007) Distinct roles of E2F proteins in vascular smooth muscle cell proliferation and intimal hyperplasia. Proceedings of the National Academy of Sciences of the United States of America. 104: 12988-93 |
Layzer JM, McCaffrey AP, Tanner AK, et al. (2004) In vivo activity of nuclease-resistant siRNAs. Rna (New York, N.Y.). 10: 766-71 |
Tanner AK, Nevins J, Sullenger B. (2004) 202. Using RNA to Inhibit Intimal Hperplasia by Blocking E2F Function Molecular Therapy. 9 |